ANGLE (LON:AGL) Given Buy Rating at Berenberg Bank

ANGLE (LON:AGL)‘s stock had its “buy” rating reiterated by Berenberg Bank in a research report issued on Wednesday,Digital Look reports. They currently have a GBX 40 ($0.50) target price on the stock. Berenberg Bank’s price target indicates a potential upside of 162.21% from the stock’s current price.

ANGLE Price Performance

Shares of LON:AGL traded up GBX 2.01 ($0.02) during trading on Wednesday, hitting GBX 15.26 ($0.19). 12,167,654 shares of the company’s stock were exchanged, compared to its average volume of 1,808,907. The business’s 50-day simple moving average is GBX 10.92 and its 200 day simple moving average is GBX 11.18. The company has a market cap of £49.20 million, a price-to-earnings ratio of -217.93 and a beta of 0.22. ANGLE has a 52-week low of GBX 7.11 ($0.09) and a 52-week high of GBX 25.13 ($0.31). The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.